Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China
โ Scribed by Fang-Hui Zhao; Shang-Ying Hu; Jessica J. Bian; Bin Liu; Roger B. Peck; Yan-Ping Bao; Qin-Jing Pan; Lucien Frappart; John Sellors; You-Lin Qiao
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 2011
- Tongue
- English
- Weight
- 208 KB
- Volume
- 119
- Category
- Article
- ISSN
- 1934-662X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND: Human papillomavirus (HPV) DNA testing using Hybrid Capture 2 assay with ThinPrep Papanicolaou (Pap) collection is the only US Food and Drug Administrationโapproved method for the triage of women with atypical squamous cells of undetermined significance (ASCUS). Although
## Background: Infection by high-risk human papillomavirus (hpv) plays a role in the evolution of cervical carcinoma. cellular atypia and consecutive dna content alterations in cytologic samples are consequences of a preexisting viral infection. ## Methods: We analyzed the frequency and associati
The APTIMA V R HPV Assay (AHPV) allows detection of 14 high-risk human papillomavirus (HPV) RNA types in cervical specimens. Until present, the assay has been compared to HPV DNA tests only in triage settings. Herein, we compare AHPV with a DNA assay (Hybrid Capture V R 2; HC2) and liquid-based cyto
## BACKGROUND. In cervical lesions, the overexpression of p16 is reported to be closely associated with high-risk human papillomavirus (HPV) infection. The objective of the current study was to confirm the usefulness of liquid-based cervical specimens for p16 staining as well as tissue sections.
## Abstract The causal relationship between persistent highโrisk human papillomavirus infection and cervical cancer is widely accepted. HRโHPV DNA testing, alone or in combination with Pap smear testing, may have a role in primary screening. The screening results (VIA, VILI, Pap, and HRโHPV DNA) of